Skip to content

Eduardo Pacheco Rico

6 papers in the library · 9 citations · publishing 2024-2026

Papers

Sort Most recent Most cited

Single ayahuasca administration mitigates long-term behavioral and neurochemical effects of early-life stress in rats.

Journal of Neural Transmission September 19, 2026 Guilherme Lodetti, Henrique Redivo, Amanda Gomes Teixeira et al.

Pharmacotherapy for depression is commonly prescribed, yet fewer than half of patients achieve remission with a single treatment. Many also experience intolerable side effects, highlighting the need for new treatment approaches. Classic psychedelics interact with the serotonin (5-HT) receptor class and are therefore strongly involved in the treatment of psychiatric illnesses such as depression,...

Single Ayahuasca administration attenuates alcohol relapse and associated behavioral, neurochemical, and oxidative alterations in rats

Progress in Neuro-Psychopharmacology and Biological Psychiatry July 1, 2026 Guilherme Lodetti, Rafael Mariano de Bitencourt, Antonio Inserra et al.

BackgroundAlcohol use disorder (AUD) remains difficult to treat with lasting success, leading to growing interest in alternative therapeutic approaches. Psychedelic compounds such as Ayahuasca, a traditional brew used in Indigenous Amazonian ceremonies containing N,N-dimethyltryptamine (DMT) along with monoamine oxidase-inhibiting β-carbolines, have shown promise in reducing addictive...

DOI: 10.1016/j.pnpbp.2026.111817 (opens in new tab) Ayahuasca Serotonin Oxidative stress Glutathione peroxidase +12

Psychedelics and autism spectrum disorder: Mechanistic insights, translational evidence and ethical challenges

Journal of Psychiatric Research June 23, 2026 Júlio César Claudino Dos Santos, Sofia Januário Bolan, Guilherme Lodetti da Silva et al.

Autism spectrum disorder (ASD) is a heterogeneous neurodevelopmental condition characterized by persistent deficits in social communication and interaction, restricted and repetitive patterns of behavior, and sensory processing alterations, frequently accompanied by anxiety, emotional dysregulation, and other psychiatric comorbidities. Despite advances in behavioral and pharmacological...

DOI: 10.1016/j.jpsychires.2026.06.035 (opens in new tab) Autism spectrum disorder Medline Spectrum functional analysis Poison control +3

Single exposure to Ayahuasca reverses chronic stress effects on sociability, anxiety, cortisol, and BDNF in zebrafish

Psychopharmacology April 14, 2026 Guilherme Lodetti, Antonio Inserra, Henrique Redivo et al.

BACKGROUND: Chronic stress is a risk factor for the development of anxiety, depression, and comorbid systemic conditions. Ayahuasca (AYA) has been used for hundreds of years and it elicits antidepressant and anxiolytic effects. However, it remains unknown whether AYA elicits a behavioral and biochemical protective effect in chronic stress. AIM OF THE STUDY: Therefore, we evaluated the...

DOI: 10.1007/s00213-026-07058-z (opens in new tab) Full text (opens in new tab) Chronic stress Zebrafish Antidepressant Neurotrophic factors +11

Bridging ancient substances and modern psychiatry: the role of classic psychedelics in depression treatment.

Neuroscience January 22, 2026 Guilherme Lodetti, Gislaine Zilli Réus, Eduardo Pacheco Rico

Pharmacotherapy for MDD is commonly prescribed to patients, yet fewer than half achieve remission. Moreover, many patients exhibit intolerant responses to pharmacological treatment, highlighting the need to explore new forms of therapy. The present work provides a narrative review of classic psychedelics as an alternative to MDD treatment. In addition, mechanisms by which psychedelics exert...

Classic psychedelics and the treatment for alcoholism.

Progress in Neuro-Psychopharmacology and Biological Psychiatry December 20, 2024 Guilherme Lodetti, Rafael Mariano de Bitencourt, Eduardo Pacheco Rico 9 citations

Alcohol is a harmful drug, and reducing its consumption is a significant challenge for users. Furthermore, alcohol dependence is often treatment-resistant, and no completely effective treatment model is available for chemical dependence. Classic psychedelics, such as LSD, psilocybin, and ayahuasca have been used in different clinical and pre-clinical trials, demonstrating promising...